Patents by Inventor Yuta FUNAKOSHI

Yuta FUNAKOSHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYCLOALKYLUREA DERIVATIVE
    Publication number: 20230088694
    Abstract: The present invention relates to a medicament for treating or preventing a disease related to orexin receptor, especially orexin type 2 receptor, comprising a new compound having a urea structure or a pharmaceutically acceptable salt thereof as an active ingredient. In more detail, the present invention relates to a medicament for treating or preventing narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, etc.
    Type: Application
    Filed: November 26, 2020
    Publication date: March 23, 2023
    Applicant: Sumitomo Dainippon Pharma Co., Ltd.
    Inventors: Eiji IDEUE, Masafumi KOMIYA, Shoukou LEE, Shunichiro UESUGI, Yuta FUNAKOSHI
  • Cycloalkylurea derivative
    Patent number: 11352357
    Abstract: The present invention relates to a medicament for treating or preventing a disease related to orexin receptor, especially orexin type 2 receptor, comprising a new compound having a urea structure or a pharmaceutically acceptable salt thereof as an active ingredient. In more detail, the present invention relates to a medicament for treating or preventing narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, etc.
    Type: Grant
    Filed: November 15, 2021
    Date of Patent: June 7, 2022
    Assignee: Sumitomo Dainippon Pharma Co., Ltd.
    Inventors: Eiji Ideue, Masafumi Komiya, Shoukou Lee, Shunichiro Uesugi, Yuta Funakoshi
  • CYCLOALKYLUREA DERIVATIVE
    Publication number: 20220081441
    Abstract: The present invention relates to a medicament for treating or preventing a disease related to orexin receptor, especially orexin type 2 receptor, comprising a new compound having a urea structure or a pharmaceutically acceptable salt thereof as an active ingredient. In more detail, the present invention relates to a medicament for treating or preventing narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, etc.
    Type: Application
    Filed: November 15, 2021
    Publication date: March 17, 2022
    Applicant: Sumitomo Dainippon Pharma Co., Ltd.
    Inventors: Eiji IDEUE, Masafumi KOMIYA, Shoukou LEE, Shunichiro UESUGI, Yuta FUNAKOSHI